TODAY: Schultze Special Purpose & Clever Leaves: Live Update and Q&A
by Kristi Marvin on 2020-11-16 at 9:17am

REMINDER: Please join Schultze Special Purpose Acquisition Corp. (SAMA) and the executive management team from Clever Leaves International Inc., for an update on the proposed merger, with Clever Leaves Advisory Board Member and former U.S. Senate Majority Leader, Tom Daschle, available to discuss the changing landscape for cannabis legalization in the US and globally. Management and Senator Daschle will walk through a brief investor presentation update and take questions from the audience.


Live Management Presentation and Q&A

 

CLICK to REGISTER

 

Please join

 

Schultze Special Purpose Acquisition Corp. (SAMA)
&
Clever Leaves Executive Management

 

for an online investor presentation and live Q&A discussion regarding their proposed merger

 

Date: Monday, November 16th
Time:  1:00 p.m. (Eastern Time)

 

SPEAKERS
Kyle Detwiler – CEO, Clever Leaves
Andres Fajardo – President, Clever Leaves
Senator Tom Daschle – Advisory Board Member, Clever Leaves
George Schultze – Chairman and CEO, SAMA
Gary Julien – EVP and Director, SAMA
Gavin O’Reilly – Managing Director, Cowen and Company

 

  * Management will be taking questions from the audience *

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved